Exenatide

Generic name
Exenatide
Brand name
ATC Code
A10BJ01
Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Type 2 diabetes mellitus
  • Subcutaneous
    • 10 years up to 18 years
      • 2 mg/dose once a week.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Biguanides
A10BA02
Sulfonylureas
A10BB01
Combinations of oral blood glucose lowering drugs
A10BD20
Glucagon-like peptide-1 (GLP-1) analogues
A10BJ05
A10BJ02
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
A10BK01
A10BK03

Reference

  1. AstraZeneca AB, SmPC Bydureon EU/1/11/696/001-002 (26-8-2022), www.ema.europa.eu

Changes

Therapeutic Drug Monitoring


Overdose